State Street SPDR S&P Pharmaceuticals ETF closed at $66.89 on Sep 28, up 1.21%, 9.7% below its 52-week closing high. Volume of 278.3K shares was 1.47× its 20-day average (above normal).
Split-adjusted performance: -7.6% over one month, +29.0% over six months, +46.0% over one year.
Short interest was 624.9K shares at the Sep 15 settlement, up 13.9% from the prior report (3.3 days to cover).
Does State Street SPDR S&P Pharmaceuticals ETF pay a dividend?
Yes. The latest regular dividend was $0.0416 per share (ex-date Sep 21), an annualised yield of 0.25%.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology